Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Glassman

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 11, 2009
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings, Alexander J Brucker, Haijing Qin, et al.
JAMA Ophthalmology|January 31, 2020
Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic RetinopathyMaureen G Maguire, Danni Liu, Adam R Glassman, et al.
JAMA Ophthalmology|November 12, 2017
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Danni Liu, et al.
Ophthalmology. Retina|October 25, 2023
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility StudyKevin J Blinder, Claire Calhoun, Maureen G Maguire, et al.
Ophthalmology|December 6, 2011
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema, , Lloyd Paul Aiello, et al.
American Journal of Ophthalmology|August 6, 2018
Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol TNeil M Bressler, Wesley T Beaulieu, Maureen G Maguire, et al.
Retina (Philadelphia, Pa.)|March 12, 2011
Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation, Joseph Googe, Alexander J Brucker, et al.
JAMA Ophthalmology|May 22, 2015
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical TrialLloyd Paul Aiello, Allison R Ayala, Andrew N Antoszyk, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Ophthalmology|April 5, 2011
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaMichael J Elman, Neil M Bressler, Haijing Qin, et al.
JAMA Ophthalmology|January 10, 2016
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision ImpairmentSusan B Bressler, Allison R Ayala, Neil M Bressler, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 11, 2009
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings, Alexander J Brucker, Haijing Qin, et al.
JAMA Ophthalmology|January 31, 2020
Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic RetinopathyMaureen G Maguire, Danni Liu, Adam R Glassman, et al.
JAMA Ophthalmology|November 12, 2017
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical TrialRaj K Maturi, Adam R Glassman, Danni Liu, et al.
Ophthalmology. Retina|October 25, 2023
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility StudyKevin J Blinder, Claire Calhoun, Maureen G Maguire, et al.
Ophthalmology|December 6, 2011
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema, , Lloyd Paul Aiello, et al.
American Journal of Ophthalmology|August 6, 2018
Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol TNeil M Bressler, Wesley T Beaulieu, Maureen G Maguire, et al.
Retina (Philadelphia, Pa.)|March 12, 2011
Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation, Joseph Googe, Alexander J Brucker, et al.
JAMA Ophthalmology|May 22, 2015
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical TrialLloyd Paul Aiello, Allison R Ayala, Andrew N Antoszyk, et al.
Pageof 13